Skip to main content
. 2021 Sep 27;55(4):409–417. doi: 10.2478/raon-2021-0037

Table 1.

Experimental data of patients qualified for the study, which include CT, histological, clinical and procedure parameters

CT parameters
Histology Clinical parameters
Procedure parameters
# HU avg
HU var
Stroke etiology Therapy before stoke NIHSS
mRS
occl nor diff diff
[%]
occl nor diff diff
[%]
L
[mm]
RBC
[%]
strt end diff strt end diff Rd
[min]
# pass
1. 29.1 32.4 -3.3 -11.4 4.20 4.42 -0.22 -5.0 20.8 11.5 AT / 21 1 20 4 1 3 42 1
2. 42.0 29.2 12.8 30.5 4.58 8.98 -4.40 -96.3 16.3 45.1 CE / 17 8 9 5 4 1 62 2
3. 38.5 35.1 3.4 8.9 3.56 2.75 0.80 22.6 17.0 12.0 CE / 23 7 16 4 3 1 65 1
4. 36.9 34.3 2.5 6.8 11.66 4.58 7.08 60.7 17.5 41.4 CE AA 18 3 15 5 2 3 77 1
5. 43.7 44.2 -0.5 -1.2 3.55 3.86 -0.31 -8.7 17.9 65.9 AT / 26 6 20 5 3 2 97 3
6. 35.8 30.0 5.9 16.4 4.17 2.23 1.95 46.7 16.3 61.0 CE / 7 0 7 3 0 3 38 3
7. 31.8 36.0 -4.2 -13.2 2.77 3.26 -0.49 -17.8 22.2 57.3 AT / 13 3 10 4 1 3 90 1
8. 37.8 38.9 -1.1 -2.9 2.82 4.45 -1.63 -58.0 26.9 50.3 CE / 14 3 11 4 3 1 77 1
9. 32.0 24.0 8.1 25.1 9.50 4.90 4.60 48.4 22.7 56.3 CE ACAA 5 2 3 3 2 1 115 2
10. 38.5 36.5 2.0 5.1 3.20 2.80 0.40 12.5 19.7 52.4 CE / 26 42 -16 5 6 -1 82 4
11. 38.3 39.4 -1.1 -2.8 5.49 3.66 1.83 33.4 17.1 19.1 AT / 12 0 12 3 0 3 60 1
12. 35.7 33.9 1.7 4.9 3.56 5.39 -1.83 -51.2 13.9 31.8 CE AA 6 3 3 3 1 2 69 1
13. 44.3 31.9 12.3 27.8 4.66 5.11 -0.46 -9.8 22.5 74.7 AT / 19 12 7 5 4 1 108 2
14. 44.1 37.5 6.6 15.0 2.60 3.92 -1.32 -50.9 19.3 38.9 CE / 18 20 -2 4 5 -1 63 5
15. 36.0 35.4 0.6 1.6 3.48 2.67 0.81 23.4 17.9 48.8 CE / 42 42 0 5 6 -1 75 2
16. 38.1 36.4 1.7 4.5 4.16 5.45 -1.30 -31.2 18.6 21.3 AT / 15 4 11 5 4 1 77 1
17. 42.5 40.7 1.8 4.2 3.11 3.74 -0.63 -20.4 13.5 14.8 CE AA 14 2 12 5 3 2 53 1
18. 38.7 23.3 15.4 39.8 5.66 4.79 0.87 15.3 19.1 42.4 CE AC 22 3 19 5 4 1 43 1
19. 34.7 30.9 3.8 11.0 5.61 4.43 1.18 21.1 20.9 37.7 AT / 3 1 2 1 0 1 60 1
20. 41.2 32.4 8.8 21.4 5.14 4.58 0.56 10.9 19.3 56.0 AT AC 11 40 -29 4 6 -2 76 3
21. 37.2 28.5 8.7 23.5 3.29 5.27 -1.99 -60.4 29.2 79.1 AT / 19 10 9 5 5 0 61 1
22. 35.2 32.5 2.6 7.5 3.02 2.79 0.24 7.9 13.6 9.3 CE / 16 9 7 5 5 0 95 3
23. 41.5 34.5 6.9 16.7 5.14 4.47 0.67 13.0 21.5 80.4 AT / 16 3 13 4 2 2 65 2
24. 28.9 23.2 5.6 19.5 3.52 4.72 -1.20 -34.1 12.1 57.1 CE / 13 3 10 4 1 3 55 1
25. 40.2 33.4 6.8 17.0 2.91 4.30 -1.39 -47.8 18.7 46.8 AT AA 42 42 0 5 6 -1 90 4

AA = antiaggregation; AC = anticoagulant; ACAA = both types of drugs; AT = atherothrombotic; CE = cardioembolic; diff = absolute difference; diff [%] = relative difference in %; HU avg = average Hounsfield units; HU var = variability of Hounsfield units; L [mm] = CT length of the thrombi; mRS = modified Rankin score; NIHSS = NIH Stroke Scale; nor = normal artery; occl = occlusion; RBC [%] = percentage of red blood cells in the thrombi; Rd = duration of mechanical recanalization; # pass = number of passes